Background Glucagon-like peptide-1 (GLP-1) is a proglucagon-derived peptide expressed in the enteroendocrine- L cells of small and large intestine and released in response to meal ingestion. Glucagon-like peptide-1 exerts inhibitory effects on gastrointestinal motility through vagal afferents and central nervous mechanisms; however, no data is available about a direct influence on the gastrointestinal wall. Our aim was to investigate the effects of GLP-1 on the spontaneous and evoked mechanical activity of mouse duodenum and colon and to identify the presence and distribution of GLP-1 receptors (GLP-1R) in the muscle coat. Methods Organ bath recording technique and immunohistochemistry were used. Key Results Glucagon-like peptide-1 (up to the concentration of 1 lmol L)1) failed to affect spontaneous mechanical activity. It caused concentration-dependent reduction of the electrically evoked cholinergic contractions in circular smooth muscle of both intestinal segments, without affecting the longitudinal muscle responses. Glucagon-like peptide-1 inhibitory effect was significantly antagonized by exendin (9–39), an antagonist of GLP-1R. In both intestinal preparations, GLP-1 effect was not affected by guanethidine, a blocker of adrenergic neurotransmission, but it was significantly reduced by Nx-nitro-L-arginine methyl ester, inhibitor of nitric oxide (NO) synthase. Glucagon- like peptide-1 failed to affect the contractions evoked by exogenous carbachol. Immunohistochemistry demonstrated GLP-1R expression in the enteric neurons. Furthermore, 27% of GLP-1R immunoreactive (IR) neurons in the duodenum and 79% of GLP- 1R-IR neurons in the colon, co-expressed nNOS. Conclusions & Inferences The present results suggest that GLP-1 is able to act in the enteric nervous system by decreasing the excitatory cholinergic neurotransmission through presynaptic GLP-1Rs, which modulate NO release.
Peripheral motor action of glucagon-like peptide-1 through enteric neuronal receptors / Amato A.; Cinci L.; Rotondo A.; Serio R; Faussone-Pellegrini M.S.; Vannucchi M.G.; Mulè F.. - In: NEUROGASTROENTEROLOGY AND MOTILITY. - ISSN 1350-1925. - ELETTRONICO. - 22(2010), pp. 664-672.
Titolo: | Peripheral motor action of glucagon-like peptide-1 through enteric neuronal receptors. | |
Autori di Ateneo: | ||
Autori: | Amato A.; CINCI, LORENZO; Rotondo A.; Serio R; PELLEGRINI, MARIA SIMONETTA; VANNUCCHI, MARIA; Mulè F. | |
Anno di registrazione: | 2010 | |
Rivista: | ||
Volume: | 22 | |
Pagina iniziale: | 664 | |
Pagina finale: | 672 | |
Abstract: | Background Glucagon-like peptide-1 (GLP-1) is a proglucagon-derived peptide expressed in the enteroendocrine- L cells of small and large intestine and released in response to meal ingestion. Glucagon-like peptide-1 exerts inhibitory effects on gastrointestinal motility through vagal afferents and central nervous mechanisms; however, no data is available about a direct influence on the gastrointestinal wall. Our aim was to investigate the effects of GLP-1 on the spontaneous and evoked mechanical activity of mouse duodenum and colon and to identify the presence and distribution of GLP-1 receptors (GLP-1R) in the muscle coat. Methods Organ bath recording technique and immunohistochemistry were used. Key Results Glucagon-like peptide-1 (up to the concentration of 1 lmol L)1) failed to affect spontaneous mechanical activity. It caused concentration-dependent reduction of the electrically evoked cholinergic contractions in circular smooth muscle of both intestinal segments, without affecting the longitudinal muscle responses. Glucagon-like peptide-1 inhibitory effect was significantly antagonized by exendin (9–39), an antagonist of GLP-1R. In both intestinal preparations, GLP-1 effect was not affected by guanethidine, a blocker of adrenergic neurotransmission, but it was significantly reduced by Nx-nitro-L-arginine methyl ester, inhibitor of nitric oxide (NO) synthase. Glucagon- like peptide-1 failed to affect the contractions evoked by exogenous carbachol. Immunohistochemistry demonstrated GLP-1R expression in the enteric neurons. Furthermore, 27% of GLP-1R immunoreactive (IR) neurons in the duodenum and 79% of GLP- 1R-IR neurons in the colon, co-expressed nNOS. Conclusions & Inferences The present results suggest that GLP-1 is able to act in the enteric nervous system by decreasing the excitatory cholinergic neurotransmission through presynaptic GLP-1Rs, which modulate NO release. | |
Handle: | http://hdl.handle.net/2158/388254 | |
Appare nelle tipologie: | 1a - Articolo su rivista |
File in questo prodotto:
File | Descrizione | Tipologia | Licenza | |
---|---|---|---|---|
Vannucchi MG Neurogastroenterol Motil 2010.pdf | Versione finale referata (Postprint, Accepted manuscript) | DRM non definito | Administrator Richiedi una copia |